Investor Relations

Sun BioPharma Inc. and its wholly owned subsidiary Sun BioPharma Pty. Ltd., is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The company’s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Sun BioPharma has scientific collaborations with pancreatic disease experts at Honor Health in Scottsdale, AZ, Cedars Sinai Medical Center in Los Angeles, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre and the Ashford Cancer Centre in Adelaide, Australia.

Sun BioPharma’s common stock is quoted on the OTCQB tier of the over-the-counter markets administered by OTC Markets Group, Inc. under the symbol SNBP.

Sign up to receive press releases via email

Press Releases

Events & Presentations

Corporate Governance

Sun BioPharma has adopted a code of business conduct and ethics regarding the conduct of all executive and other officers, employees and agents. It is our policy to comply strictly with all laws governing our operations and to conduct our affairs in keeping with the highest moral, legal and ethical standards.

Audit Committee Charter
Code of Business Conduct and Ethics
Compensation Committee Charter
Disclosure Policy
Insider Trading Policy
Nominating and Governance Committee Charter
Related Person Transaction Approval Policy
Whistleblower Policy

Committee Composition
Independent DirectorsAuditCompensationNominating & Governance
Jeffrey S. MathiesenCX
J. Robert Paulson, Jr.XC
Paul W. SchafferXXX
D. Robert SchemelXC

C = Chair   X = Member

Stock Transfer Agent and Registrar

VStock Transfer, LLC acts as transfer agent and registrar for Sun BioPharma and maintains all shareholder records for the company. Should you have questions regarding the Sun BioPharma stock you own, stock transfers, or address or name changes, please contact VStock Transfer by writing or calling:

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Toll-Free: (855) 9VSTOCK
Fax: (646) 536-3179
Email: [email protected]

Independent Auditors: Cherry Bekaert
401 East Jackson St, Suite 3400
Tampa, FL 33602
Phone: (813)-251-1010
Fax: (813) 251-9235

Leadership

Company Management

Michael T. Cullen, M.D., MBA, Co-Founder, Chief Executive Officer and Executive Chairman
Susan Horvath, Vice President and Chief Financial Officer
Thomas X. Neenan, Ph.D., Co-Founder and Chief Scientific Officer
Suzanne Gagnon, M.D., Chief Medical Officer
Tammy Groene, Vice President of Operations and Corporate Secretary
Anthony L. Kiorpes, Ph.D., DVM, Toxicology Consultant
Michael Walker, M.D., Director of Pancreatic Research
Kristen Flaharty, Pharmacology Consultant

Board of Directors – Sun BioPharma, Inc.

Michael T. Cullen, M.D., MBA, Co-Founder, Chief Executive Officer and Executive Chairman
Robert Schemel, Chairman of the Compensation Committee and Member of the Nominating and Corporate Governance Committee
Paul W. Schaffer, PharmD, Member of the Compensation and Audit Committee
J. Robert Paulson, Jr., MBA, Chairman of the Nominating and Corporate Governance Committee and Member of Audit, Compensation Committee
Jeff Mathiesen, Chairman of the Audit Committee, Member of the Nominating and Corporate Governance Committee
Suzanne Gagnon, M.D., Chief Medical Officer

Board of Directors – Sun BioPharma Australia Pty. Ltd.

Michael T. Cullen, M.D., MBA, Co-Founder, Chief Executive Officer and Executive Chairman
David Harle, Ph.D., Board Member

Back to top

Financial Information

Annual Reports & Proxy Statements

Contact Us

 

Investor Relations Contact:
Susan Horvath: 952-479-1196

Media Contact:
Tammy Groene: 952-479-1196

Sun BioPharma

(952) 479-1196
[email protected]